237 related articles for article (PubMed ID: 15477209)
21. Thawing of cryopreserved mobilized peripheral blood--comparison between waterbath and dry warming device.
Röllig C; Babatz J; Wagner I; Maiwald A; Schwarze V; Ehninger G; Bornhäuser M
Cytotherapy; 2002; 4(6):551-5. PubMed ID: 12568991
[TBL] [Abstract][Full Text] [Related]
22. Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products.
Civriz Bozdag S; Bay M; Ayyıldız E; Topcuoglu P; Ilhan O
Transfus Apher Sci; 2012 Aug; 47(1):117-20. PubMed ID: 22609193
[TBL] [Abstract][Full Text] [Related]
23. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
24. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
25. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
26. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
27. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations.
Foïs E; Desmartin M; Benhamida S; Xavier F; Vanneaux V; Rea D; Fermand JP; Arnulf B; Mounier N; Ertault M; Lotz JP; Galicier L; Raffoux E; Benbunan M; Marolleau JP; Larghero J
Bone Marrow Transplant; 2007 Nov; 40(9):831-5. PubMed ID: 17724443
[TBL] [Abstract][Full Text] [Related]
28. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
[TBL] [Abstract][Full Text] [Related]
29. Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.
Schwaber MJ; Krasner CN; Gold HS; Venkataraman L; Avigan DE; Karchmer AW; Uhl L
J Clin Apher; 2003; 18(1):37-9. PubMed ID: 12717792
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.
Corrias MV; Haupt R; Carlini B; Parodi S; Rivabella L; Garaventa A; Pistoia V; Dallorso S
Clin Cancer Res; 2006 Oct; 12(19):5680-5. PubMed ID: 17020970
[TBL] [Abstract][Full Text] [Related]
31. A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience.
Abbruzzese L; Michieli M; Rupolo M; Toffola RT; Da Ponte A; Rossi FM; Lorenzon D; Simonelli C; Gattei V; De Marco L; Mazzucato M
Vox Sang; 2010 Feb; 98(2):172-80. PubMed ID: 19695012
[TBL] [Abstract][Full Text] [Related]
32. Collection and use of peripheral blood stem cells in very small children.
Lasky LC; Fox SB; Smith J; Bostrom B
Bone Marrow Transplant; 1991 Apr; 7(4):281-4. PubMed ID: 1676923
[TBL] [Abstract][Full Text] [Related]
33. Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution.
Mele L; Dallavalle FM; Verri MG; Balza G; Allione B; Salvi F; Levis A; Caraccio V; Borzini P
Transfus Apher Sci; 2005 Nov; 33(3):269-74. PubMed ID: 16239124
[TBL] [Abstract][Full Text] [Related]
34. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
[TBL] [Abstract][Full Text] [Related]
35. The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization.
Keane C; Gibbs S; Seymour JF; Mills AK; Grimmett K; Van Kuilenberg R; Saal R; Gill D; Prince HM; Marlton P; Mollee P
Hematol Oncol; 2006 Sep; 24(3):159-63. PubMed ID: 16775841
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
[TBL] [Abstract][Full Text] [Related]
37. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
[TBL] [Abstract][Full Text] [Related]
38. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
[TBL] [Abstract][Full Text] [Related]
39. Autologous transplant: microbial contamination of hematopoietic stem cell products.
Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
[TBL] [Abstract][Full Text] [Related]
40. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
